Načítá se...
Molecular mechanism of statin-mediated LOX-1 inhibition
Statins are largely used in clinics in the treatment of patients with cardiovascular diseases for their effect on lowering circulating cholesterol. Lectin-like oxidized low-density lipoprotein (LOX-1), the primary receptor for ox-LDL, plays a central role in the pathogenesis of atherosclerosis and c...
Uloženo v:
| Vydáno v: | Cell Cycle |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4614984/ https://ncbi.nlm.nih.gov/pubmed/25950192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1026486 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|